What price will the next raising be? Failed miserably at 1.8c with no director interest and since then bioeffective deal has been put in serious jeopardy.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025